Skip to main content
Home

oAv Menu

  • Home
  • Patient Care Center
  • Clinical Trials
  • Providers
    • Therapeutics
    • People
    • Places
  • Community Center
    • Community Stories
    • Social Media
    • Community Content
    • Financial Assistance
  • News
    • Community Events
    • Clinical Trials and Research
    • Business
    • News People
    • Happenings
    • Spotlight
    • Fundraising Events
  • Trusted Resources
    • Education
    • Videos & Visuals
  • Event Calendar
  • Login
  • Search
amyloidosis
Living with Hope After an ATTR-Cardiac Amyloidosis (ATTR-CM) Diagnosis
Jun 18, 2026

News

Saygı Hastanesi
Tafamidis: Transthyretin Stabilizer Therapy
Jun 25, 2026
Saygı Hastanesi
Patisiran and Inotersen in hATTR Amyloidosis
Jun 25, 2026
mdedge
Case Series of Patients With Cardiac Amyloidosis at VA New York Harbor Healthcare-Brooklyn
Jun 23, 2026
AJMC
ATTR-CM Incidence, Prevalence Rose Sharply in the US
Jun 23, 2026
amyloidosis
Finger tapping test catches early, subtle nerve damage in hATTR-PN
Jun 22, 2026
More in News

Education

amyloidosis
Recognizing and Managing Neurological Symptoms of ATTR-CM
Jun 23, 2026
amyloidosis
Cardiac Amyloidosis: Early Clues, Testing, and Treatment Options
Jun 22, 2026
saygi
PYP Scintigraphy in ATTR Cardiac Amyloidosis
Jun 22, 2026
Saygı Hastanesi
Advanced Approach to Cardiac Amyloidosis
Jun 20, 2026
National Organization for Rare Disorders | NORD
Amyloidosis
Jun 17, 2026
More in Education

Community Center

amyloidosis
Temple Johnson Woodrum's Post
Jun 23, 2026
amyloidosis
Alliance for Patient Access's Post
Jun 19, 2026
amyloidosis
hattrnextgen
Jun 18, 2026
amyloidosis
Living with Hope After an ATTR-Cardiac Amyloidosis (ATTR-CM) Diagnosis
Jun 18, 2026
amyloidosis
Fred Hutch's Post
Jun 17, 2026
More in Community Center

Video

Newsletter

Stay informed - subscribe to our newsletter.
The subscriber's email address.

RNAi Explained

Dr. Bersell explores RNA interference (RNAi) technology and its applications in treating ATTR-CM and ATTR-PN. Learn about mechanism of action, clinical evidence, and patient outcomes.

Learn More

Expert Perspectives on Attruby®

Dr. Barry Trachtenberg and ATTR community members discuss Attruby™ (acoramidis), covering clinical data, patient perspectives, and treatment considerations.

Watch Discussion

Featured Trials

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ALN-TTRSC04 in Healthy Subjects
Collection of Samples and Clinical Data From Patients With Amyloid Diseases
Ohio State University Multiple Myeloma and Amyloidosis Data Registry and Sample Resource
Post Approval Study of Lixelle for the Treament of Dialysis-Related Amyloidosis
Molecular Imaging of Primary Amyloid Cardiomyopathy

Footer menu

  • Home
  • About us
  • Video
  • Galleries
  • Contact
  • Login
  • Privacy Policy
  • Privacy Reminder
  • Terms of use
  • FAQ
  • Code of Conduct

© 2025 Somebody To Talk To, Inc.

Join us on                     
Alnylam Logo external link, opens in a new tabPfizer Logo external link, opens in a new tabBridgebio Logo external link, opens in a new tabAttralus Logo external link, opens in a new tabProthena Logo external link, opens in a new tab
Amyloidosis Foundation Logo external link, opens in a new tab